Invesco Ltd. - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 221 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 12.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$18,884,829
-41.4%
410,629
-26.8%
0.01%
-37.5%
Q2 2023$32,221,934
+45.0%
560,674
-5.4%
0.01%
+33.3%
Q1 2023$22,228,839
+22.8%
592,769
-8.2%
0.01%
+20.0%
Q4 2022$18,099,772
+9.5%
645,959
+9.9%
0.01%0.0%
Q3 2022$16,522,000
-6.9%
587,943
+15.3%
0.01%0.0%
Q2 2022$17,744,000
-32.6%
510,047
-30.5%
0.01%
-28.6%
Q1 2022$26,344,000
+62.3%
733,842
+5.3%
0.01%
+75.0%
Q4 2021$16,230,000
+19.5%
696,889
-2.4%
0.00%
+33.3%
Q3 2021$13,579,000
-14.6%
714,319
-9.4%
0.00%
-25.0%
Q2 2021$15,895,000
-7.1%
788,414
-15.6%
0.00%
-20.0%
Q1 2021$17,104,000
-39.0%
933,646
-33.1%
0.01%
-37.5%
Q4 2020$28,055,000
+10.8%
1,395,047
+3.3%
0.01%
-11.1%
Q3 2020$25,320,000
-11.2%
1,350,417
+6.4%
0.01%
-10.0%
Q2 2020$28,499,000
+158.8%
1,268,877
+71.0%
0.01%
+100.0%
Q1 2020$11,013,000
-48.1%
742,147
-32.6%
0.01%
-28.6%
Q4 2019$21,238,000
+58.7%
1,100,992
+63.1%
0.01%
+75.0%
Q3 2019$13,385,000
+126.5%
674,980
+141.1%
0.00%
+100.0%
Q2 2019$5,909,000
-66.6%
279,907
-67.7%
0.00%
-66.7%
Q1 2019$17,708,000
-20.0%
866,785
-22.1%
0.01%
-25.0%
Q4 2018$22,146,000
+127.7%
1,112,867
+120.2%
0.01%
+166.7%
Q3 2018$9,725,000
+106.6%
505,438
+63.9%
0.00%
+50.0%
Q2 2018$4,707,000
-74.9%
308,474
-69.2%
0.00%
-71.4%
Q1 2018$18,765,000
-3.5%
1,000,797
-1.0%
0.01%0.0%
Q4 2017$19,447,000
-18.6%
1,010,740
-24.4%
0.01%
-22.2%
Q3 2017$23,880,000
+0.4%
1,336,330
+0.4%
0.01%
+28.6%
Q2 2017$23,782,000
+732.4%
1,331,600
+575.9%
0.01%
+600.0%
Q1 2017$2,857,000
+8.3%
197,020
+37.5%
0.00%0.0%
Q4 2016$2,639,000
-12.9%
143,289
-10.3%
0.00%0.0%
Q3 2016$3,030,000
+835.2%
159,753
+695.2%
0.00%
Q2 2016$324,000
+26.1%
20,089
-6.4%
0.00%
Q1 2016$257,000
+5040.0%
21,453
+6887.9%
0.00%
Q2 2015$5,0003070.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q2 2022
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$3,649,6053.75%
SHAKER INVESTMENTS LLC/OH 81,287$2,277,6621.41%
Mesirow Institutional Investment Management, Inc. 374,414$10,491,0801.38%
OBERWEIS ASSET MANAGEMENT INC/ 134,000$3,754,6800.80%
Portolan Capital Management 270,791$7,587,5640.75%
Hillsdale Investment Management Inc. 172,238$4,826,1090.41%
Capital Impact Advisors, LLC 14,669$411,0250.40%
Watershed Asset Management, L.L.C. 9,555$267,7310.34%
Quantedge Capital Pte Ltd 35,153$984,9870.33%
FEDERATED HERMES, INC. 3,284,217$92,023,7600.25%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders